BSAVA has published a new scientific information document on the use of cannabidiol (CBD) in cats and dogs.
The document outlines the legal position regarding the use of CBD oil in dogs and cats in the UK and the pharmacokinetics and pharmacodynamics of CBD in humans and dogs. Written by members of BSAVA Scientific Committee, together with specialists in internal medicine and neurology, the document also contains an overview of current scientific research.
Caroline Kisielewicz, BSAVA Scientific Committee member and one of the authors of the document said: “Information regarding the effects of cannabinoids on animals is predominantly at the stage of pre-clinical testing of individual substances in mice, rats and guinea pigs. There are limited clinical studies looking at the effects of CBD in dogs, and no reported studies in cats.
“There are many reports describing possible beneficial effects and therapeutic potential in humans, and subsequently pet owners may ask their vet about using cannabinoids to treat veterinary patients. This document aims to provide a broad overview of the available evidence base and legal position in the UK for veterinary team members.”
BSAVA President, Ian Ramsey added: “The development of this information is in direct response to an increased interest in the use of CBD to treat cats and dogs. Furthermore, the guidance supports BSAVA’s mission to promote excellence in small animal practice through community, education and science.”
The Use of cannabidiol (CBD) in dogs and cats
information document is freely available to everyone and can be accessed online.
